Available Technologies

Licensed Technologies

Nutrition

Education

• LPC - Diagnostics: Vanteres
• LPC - Delivery Across BBB: Travecta Therapeutics
• Anti-IL11 - Fibrosis: Enleofen Bio; then licensed to Boehringer Ingelheim
• 5-HTP Formulations: Evecxia Therapeutics
• Mnk Inhibitors for Blood Cancers: AUM Biosciences
• Anti-Cancer Drug Candidate / Chemoprotection: Under Option
• CTL-Antigen Pairs for Cancer: PairX Bio

Diagnostics

• Surrogate Virus Neutralisation Test - cPass: GenScript

Vaccines

• Covid-19 Vaccine: Arcturus Therapeutics (co-development)

Available Technologies
for Licensing / Partnering

Therapeutics

• HSPC Expansion
  
• WARS2 Therapeutic Target
• Development of Live Attenuated Viruses
• Laminin: Keratinocytes for Burns
• Laminin: Cardiac Progenitor Cells for Heart Diseases
• WWP2 for Fibrosis
• Treatment of Virus-Induced Thrombocytopenia
• Preventing Foetal Transmission of Zika Virus
• Inhibiting BK Channels for Treating Angelman Syndrome
• HBV-Specific T Cells for Hepatocellular Carcinoma
• Isoprenylcysteine Carboxyl Methyltransferase for Oncology

• Integrating Spatial Transcriptomics Data with PRECAST

Ongoing CTeD Incubation Projects

Therapeutics

• Mnk Inhibitors for Glioblastoma
• Treatment of Vascular Pathology in Coronavirus Infection

Diagnostics

• Wnt Companion Diagnostics
• Prognosticating Effectiveness of JNK Inhibitors